FDA Drug Application (201192) for TELMISARTAN AND HYDROCHLOROTHIAZIDE by TORRENT PHARMS LTD

Back to FDA Applications sponsored by TORRENT PHARMS LTD

Application Number201192
Product Number001
FormTABLET;ORAL
Dosage12.5MG;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTELMISARTAN AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TELMISARTAN

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient TELMISARTAN7


Back to FDA Applications sponsored by TORRENT PHARMS LTD